H. Ekert

3.1k total citations
136 papers, 2.3k citations indexed

About

H. Ekert is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Ekert has authored 136 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hematology, 29 papers in Genetics and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Ekert's work include Hemophilia Treatment and Research (30 papers), Blood Coagulation and Thrombosis Mechanisms (24 papers) and Acute Lymphoblastic Leukemia research (21 papers). H. Ekert is often cited by papers focused on Hemophilia Treatment and Research (30 papers), Blood Coagulation and Thrombosis Mechanisms (24 papers) and Acute Lymphoblastic Leukemia research (21 papers). H. Ekert collaborates with scholars based in Australia, United States and United Kingdom. H. Ekert's co-authors include Elizabeth Smibert, Tim Godber, Vicki Anderson, Keith Waters, Robert Powell, Ian Toogood, G. P. Tauro, Gerald S. Gilchrist, Peter J. Smith and Denman Hammond and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

H. Ekert

133 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Ekert Australia	23	959	572	473	442	395	136	2.3k
C. Philip Steuber United States	23	1.1k 1.1×	896 1.6×	460 1.0×	331 0.7×	209 0.5×	63	2.0k
G. Cornu Belgium	21	873 0.9×	354 0.6×	424 0.9×	736 1.7×	155 0.4×	60	1.9k
Margaret P. Sullivan United States	29	301 0.3×	624 1.1×	395 0.8×	311 0.7×	534 1.4×	75	2.0k
Elaine Morgan United States	26	750 0.8×	720 1.3×	647 1.4×	227 0.5×	417 1.1×	84	2.9k
Mauro Montanari Italy	25	681 0.7×	520 0.9×	561 1.2×	304 0.7×	191 0.5×	75	2.3k
P. Jean Henslee‐Downey United States	27	1.9k 2.0×	559 1.0×	543 1.1×	337 0.8×	260 0.7×	55	3.3k
Luís Madero Spain	26	813 0.8×	337 0.6×	570 1.2×	287 0.6×	257 0.7×	100	1.9k
Patrick J. Buckley United States	27	548 0.6×	355 0.6×	220 0.5×	187 0.4×	155 0.4×	93	2.2k
M M Reid United Kingdom	24	440 0.5×	289 0.5×	210 0.4×	166 0.4×	159 0.4×	80	1.5k
Jerry Stein Israel	27	793 0.8×	332 0.6×	318 0.7×	317 0.7×	177 0.4×	119	2.3k

Countries citing papers authored by H. Ekert

Since Specialization

Citations

This map shows the geographic impact of H. Ekert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Ekert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Ekert more than expected).

Fields of papers citing papers by H. Ekert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Ekert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Ekert. The network helps show where H. Ekert may publish in the future.

Co-authorship network of co-authors of H. Ekert

This figure shows the co-authorship network connecting the top 25 collaborators of H. Ekert. A scholar is included among the top collaborators of H. Ekert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Ekert. H. Ekert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reid, Susan, Jane Halliday, Michael Ditchfield, et al.. (2005). Factor V Leiden mutation: a contributory factor for cerebral palsy?. Developmental Medicine & Child Neurology. 48(1). 14–19. 17 indexed citations

McPherson, Jean, Lochie Teague, J. V. Lloyd, et al.. (1996). Experience with Recombinant Factor VIla in Australia and New Zealand. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 1). 109–117. 16 indexed citations

Brisco, M. J., John T. Condon, Elizabeth Hughes, et al.. (1994). Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. The Lancet. 343(8891). 196–200. 211 indexed citations

Ekert, H., T. F. Fok, Luciano Dalla‐Pozza, et al.. (1993). A pilot study of EVAP/ABV chemotherapy in 25 newly diagnosed children with Hodgkin's disease. British Journal of Cancer. 67(1). 159–162. 9 indexed citations

Palasanthiran, Pamela, John B. Ziegler, Andrew S. Kemp, et al.. (1990). Zidovudine (AZT) therapy in children with HIV infection: the Australian experience. Journal of Paediatrics and Child Health. 26(5). 257–262. 5 indexed citations

Ekert, H.. (1989). Childhood cancer : understanding and coping. 3 indexed citations

Barnes, Graeme, et al.. (1989). INFECTIOUS DIARRHEA IN CHILDREN UNDERGOING BONE‐MARROW TRANSPLANTATION. Australian and New Zealand Journal of Medicine. 19(1). 31–36. 16 indexed citations

Ekert, H., et al.. (1988). Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.. Journal of Clinical Oncology. 6(12). 1845–1850. 64 indexed citations

Georgiou, George, et al.. (1983). CFU-c enrichment from human bone marrow using a discontinuous Percoll gradient and soybean agglutinin in comparison with Ficoll-paque.. PubMed. 53(2). 491–6. 11 indexed citations

10.

Ekert, H. & Keith Waters. (1983). Results of Treatment of 18 Children With Hodgkin Disease With MOPP Chemotherapy as the Only Treatment Modality. Medical and Pediatric Oncology. 11(5). 322–326. 19 indexed citations

11.

Ekert, H.. (1982). Clinical paediatric haematology and oncology. 1 indexed citations

12.

Sinniah, D., et al.. (1981). Intracranial hemorrhage and circulating coagulation inhibitor in β-thalassemia major. The Journal of Pediatrics. 99(5). 700–703. 9 indexed citations

13.

Ekert, H., et al.. (1977). High incidence of cardiomyopathy in children treated with adriamycin and DTIC in combination chemotherapy.. PubMed. 61(9). 1736–8. 21 indexed citations

14.

Ekert, H., et al.. (1977). Intermittent chemotherapy and bcg in continuation therapy of children with acute lymphocytic leukemia. Medical and Pediatric Oncology. 3(1). 85–91. 5 indexed citations

15.

Price, D. A., et al.. (1977). The Use of Non-activated Prothrombin Concentrate in the Management of Haemophilia A with Factor VIII Antibodies. Australian and New Zealand Journal of Medicine. 7(3). 286–290. 5 indexed citations

16.

McVeagh, Patricia & H. Ekert. (1975). Hepatotoxicity of chemotherapy following nephrectomy and radiation therapy for right-sided Wilms tumor. The Journal of Pediatrics. 87(4). 627–628. 15 indexed citations

17.

Ekert, H., et al.. (1974). Hemorrhage in a neonate possibly due to maternal ingestion of salicylate. The Journal of Pediatrics. 84(4). 556–557. 22 indexed citations

18.

Powell, Harley R. & H. Ekert. (1974). Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome. The Journal of Pediatrics. 84(3). 345–349. 29 indexed citations

19.

Ekert, H., et al.. (1974). Preoperative and postoperative platelet function in cyanotic congenital heart disease. Journal of Thoracic and Cardiovascular Surgery. 67(2). 184–190. 22 indexed citations

20.

Ekert, H., et al.. (1972). Short courses of cytosine arabinoside and L-asparaginase in children with acute leukemia. Cancer. 30(3). 643–647. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact